Clinica Univ. de Navarra 1

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Daratumumab	Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Active, not recruiting	Phase 3	2026-09-25		NCT05438043
A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis	Nutritional and Metabolic Diseases, amyloidosis, metabolic disease, proteostasis deficiencies	Active, not recruiting	Phase 2	2026-09-25		NCT05250973

Clinical trials